Tratamento dialítico em pacientes com lesão renal aguda secundária a Covid-19: revisão integrativa

Abstract

Elderly patients, patients with heart disease or a history of kidney disease have a high chance of developing kidney damage secondary to COVID-19. 5 Healthcare professionals must deal with SARS-CoV-2 infection, loss of kidney function, and renal replacement therapy. OBJECTIVE: To understand the risks, benefits and clinical indications of renal replacement therapy in the treatment of patients with acute kidney injury secondary to COVID-19. METHOD: The present work is an integrative literature review of existing literature on the topic addressed, seeking to add together the results and develop an explanation of the phenomenon studied. A total of 116 publications were found in the BVS (n= 107), PubMed (n=4), SciELO (n=5) databases and, based on the exclusion criteria, 75 were eliminated and only 41 articles were selected, 19 were excluded and included only 23. RESULTS: Some patients recover from kidney injury during hospitalization or at the time of hospital discharge, in other cases kidney function does not fully recover, meaning that the patient may require renal replacement therapy after hospital discharge due to the injury acute kidney injury or progressing to chronic kidney disease. CONCLUSION: There is no specific treatment for Acute Kidney Injury (AKI) secondary to COVID-19 and it is only possible to prevent the onset of the disease with preventive measures or perform renal replacement therapy.